SJ

Surya Jain

Active Director Director DIN 09518679
DIN 09518679 First appointment Feb 2022 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Surya Jain

Data last updated:

Surya Jain is a Director at Kshimil Pharma Private Limited (since 2022). The company operates in Manufacturing. Kshimil Pharma Private Limited reported revenue of ₹19.2 Lakh (FY 2025).

DIN 09518679
Primary Designation Director
Industry Manufacturing
First Appointment 24 Feb 2022
Oldest Company Age 4 yrs
Largest company Kshimil Pharma Private Limited · ₹19.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kshimil Pharma Private Limited U33209DL2022PTC394283
Director24 Feb 20222022₹19.2 Lakh (FY 2025)Active

Board colleagues of Surya Jain

NameDINCompanyDesignation
Ashwini Jain09518678Kshimil Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kshimil Pharma Private Limited
Premium access

Shareholding and investment profile for Surya Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surya Jain

Surya Jain currently holds 1 directorship: Kshimil Pharma Private Limited (Director, since 24 Feb 2022, revenue ₹19.2 Lakh (FY 2025)).

Surya Jain was first appointed on 24 Feb 2022 as Director at Kshimil Pharma Private Limited.

The current boards of Surya Jain's companies include Ashwini Jain (Kshimil Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available